Mansalinog, Emilyn B.
HRN: 22-26-8401 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
01/05/2023
IV
1.5
Q8H
S/p CS
Waiting Final Action
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
01/05/2023
IV
1.5
Q8H
S/p CS
Waiting Final Action
01/05/2023
CEFUROXIME 1.5GM (VIAL)
01/05/2023
01/11/2023
IV
1.5
Q8H
AGE W/ Mild DHN
Waiting Final Action